Searchable abstracts of presentations at key conferences in endocrinology

ea0011p813 | Thyroid | ECE2006

Liver enzymes alterations during high dose intravenous glucocorticoid pulse therapy for graves’ ophthalmopathy: frequency and putative risk factors

Altea MA , Morabito E , Menconi F , Piccione R , Latrofa F , Mazzi B , Bartalena L , Pinchera A , Marcocci C , Marinò M

Recently, we have reported a few cases of acute liver damage in patients with Graves’ ophthalmopathy (GO), during or following high dose intravenous (iv) glucocorticoid (GC) pulse therapy. In the present study we analyzed retrospectively liver enzymes (LE) in 294 consecutive patients with GO who underwent ivGC. LE were measured before or during ivGC, and in 91 patients also within 6 months after ivGC. An asymptomatic increase in LE (AST peak: 67–88 U/L, ALT peak: 75&...

ea0011p812 | Thyroid | ECE2006

Rap (LDL receptor-associated protein) expression in thyroid epithelial cells: evidence for tsh-dependence in vivo and in vitro

Botta R , Lisi S , Pinchera A , Segnani C , Cianferotti L , Altea MA , Menconi F , Mattii L , Corsini GU , Marcocci C , Dolfi A , Bernardini N , Marinò M

RAP (LDL receptor associated protein) is a 44 kDa endoplasmic reticulum (ER) resident molecular chaperone. In the thyroid RAP is required for expression of megalin, an endocytic receptor responsible for transcytosis of thyroglobulin (Tg), but it also binds to Tg itself, suggesting it may affect thyroid function in various manners. Indeed, findings in RAP KO mice indicate that disruption of the RAP gene results in impaired Tg storage into the colloid, suggesting that RAP serves...